Varun Sriram 
Dealstreet

JSA advises Levim Lifetech on sale of 30% stake to Eris Lifesciences

The acquisition is aimed at expansion of Levim Lifetech's biotechnology footprint across a wide range of products and technologies.

Bar & Bench

JSA Advocates & Solicitors advised Levim Lifetech Limited on the sale of a 30% stake to Eris Lifesciences Limited for an investment of ₹54 crore

JSA advised Levim Lifetech on this transaction.

The transaction team was led by Varun Sriram (Partner) with support from Bharkavi S (Senior Associate), Associates Nithyashree Venkatesh, Maheema Senthilkumar & Sudha Putrevu.

The acquisition is aimed at expansion of Levim Lifetech's biotechnology footprint across a wide range of products and technologies.

Eris Lifesciences Ltd, established in 2007 and headquartered in Ahmedabad, India, is a publicly listed pharmaceutical company specializing in domestic branded formulations. The company focuses on chronic and sub-chronic lifestyle-related therapies, including anti-diabetes, cardiology, nutrition, and neuropsychiatry.

Levim Lifetech Pvt Ltd is an Indian biotechnology company specializing in the development and commercialization of biopharmaceutical products. The company focuses on leveraging cutting-edge science to bring evidence-based therapies to the market.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Proof of motive not necessary to sustain murder charge: Delhi High Court

Can the blind see? Delhi High Court has a unique answer as it rules in favour blind candidate for AAI selection

Kerala lawyers object to Supreme Court view on High Courts entertaining anticipatory bail pleas ahead of sessions courts

Rajasthan High Court halts import and sale of GM food items until Centre frames regulations

AZB Senior Partner Sunila Awasthi leaves to join Lex Jurists

SCROLL FOR NEXT